我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

健脾清肠法改善化疗致结直肠癌患者肠屏障功能障碍的临床观察(PDF)

《云南中医学院学报》[ISSN:1000-2723/CN:53-1048/R]

期数:
2014年03期
页码:
51-56
栏目:
临床研究
出版日期:
2014-06-25

文章信息/Info

Title:
Clinical Observation on Therapeutic Effects of Strengthening Spleen and Clearing Intestinal Treatment on Intestinal Barrier Dysfunction in Patients after Chemotherapy with Colorectal Cancer
作者:
付晓伶张彦博周荣耀△王文海
上海中医药大学附属曙光医院,上海 201203
Author(s):
FU Xiao-ling ZHANG Yan-bo ZHOU Rong-yao WANG Wen-hai
Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
关键词:
健脾清肠法 肠屏障功能障碍 脾虚湿热证 结直肠癌 化疗
Keywords:
strengthening spleen and clearing intestinal decoction intestinal barrier dysfunction spleen deficiency and damp-heat accumulation syndrome colorectal cancer chemotherapy
分类号:
R273
DOI:
-
文献标识码:
A
摘要:
目的观察健脾清肠法改善化疗致结直肠癌患者肠黏膜屏障功能障碍的临床疗效,并探讨可能作用机制。方法采用随机同期对照原则,将82例患者分成空白对照组26例(予单纯化疗)、培菲康组26例(予培菲康联合化疗)和中药组30例(予健脾清肠方药联合化疗),经治疗2个月,分别于治疗前后对结直肠癌患者予KPS行为状态评分,中医证侯总积分和单项症状积分,并检测血浆内毒素含量和尿乳果糖/甘露醇排泄率。结果中药组治疗后患者KPS评分显著高于对照组(P<0.05),其改善脾虚湿热证有效率为83.33%,显著高于对照组(P<0.05)。健脾清肠方药对“大便溏薄”、“腹痛”、“纳呆”、“肠鸣”、“倦怠乏力”、“面色萎黄”症状改善明显(P<0.05),而空白对照组和培菲康组症状出现不同程度加重。对“大便溏薄”、症状改善与培菲康组作用相近(P>0.05),中药组治疗后血浆内毒素含量、尿乳果糖/甘露醇排泄率均显著降低(P<0.05);且与培菲康组作用相近(P>0.05)。结论具有健脾清肠功效的中药能修复结直肠癌患者肠黏膜屏障损伤和改善脾虚湿热证的临床症状,提高生活质量。其可能机制主要是通过降低血内毒素含量和尿乳果糖/甘露醇比值,从而减少肠黏膜屏障通透性改变,改善肠屏障功能障碍。
Abstract:
Objective To observe the clinical effects of“strengthening spleen and clearing intestinal treatment ”on intestinal barrier dysfunction in patients after chemotherapy with colorectal cancer, and its mechanism. Methods 82 cases of intestinal barrier dysfunction in patients after chemotherapy with colorectal cancer were divided into three groups, the blank control group in which 26 cases were treated by single chemotherapy, the control group of Bifico in which 26 cases were treated by Bifico, while the treatment group of traditional Chinese medicine were given strengthening spleen and clearing intestinal decoction. Before and after the treatment for two mouths, KPS score, overall accumulate points and single point of TCM symptoms were all aberserved, the blood endotoxin concentration and the ratio of urine lactulose to mannitol(L/M)were also detected. Results Treatment group can raise scores on the quality of life(P<0.05). The efficiency of treatment group which can improve significantly clinical symptoms of spleen deficiency and damp-heat accumulation in patients is 83. 33%(P<0.05), which is higher than the other groups. This decoction can significantly improve symptoms of “loose stool, abdomen pain, poor appetite, borborygmus, tiredness, yellow complexion”(P<0.05). The blank control group and the Bifico control group can make some symptoms aggravating in different degree. It can also produce the same effect with Bifico for “loose stool ”. (P>0.05)Strengthening spleen and clearing intestinal decoction and Bifico can all decrease significantly endotoxin, urine lactulose / mannitol ratio(P<0.05). Conclusion Strengthening spleen and clearing intestinal decoction can significantly ameliorate intestinal barrier dysfunction in patients with colorectal cancer, improve clinical symptoms of spleen deficiency and damp-heat accumulation

参考文献/References

[1] 蒙烨. 化疗药物对肠黏膜屏障的损伤及其防治[J]. 医学综述,2012,18(9):1325-1327.
[2] 华永庆,段金廒,钱大玮,等. 胃肠道系统功能评价技术体系的建立及其在中药配伍禁忌研究中的应用[J]. 世界科学技术,2012,14(3):1553-1561.
[3] Stephen BE,David RB,Carolyn CC,et al. AJCC Cancer Staging Manual[J]. Berlin:Springer,2010,14(7):143-164.
[4] 刘荫华,徐玲,姚宏伟. 2010结直肠癌诊治观点科学解读[J]. 中国实用外科杂志,2010,30(9):763-768.
[5] 郭传勇,王兴鹏. 加强肠道屏障功能障碍的临床诊治研究[J]. 上海医学,2010,33(1):98-99.
[6] 中华医学会消化病学分会. 肠屏障功能障碍临床诊治建议[J]. 中华消化杂志,2006,26(9):620.
[7] 黄晓曦,王兴鹏,吴恺,等. 肠屏障功能障碍临床评估指标建立的初步研究[J]. 中华消化杂志,2006,28(8):519-522.
[8] 刘国华,张明岛. 上海市中医病证诊疗常规[M]. 上海:上海中医药大学出版社,2003:133-136.
[9] 郑筱萸. 中药新药临床研究指导原则[M]. 北京:人民卫生出版社,2002:216-225.
[10] 周浩,沈克平. 胃肠安治疗大肠癌术后脾虚证的临床研究[J]. 上海中医药杂志,2009,43(6):36-38.
[11] 刘芳,张瑞霞. 血内毒素定量测定在革兰阴性菌败血症诊断中的临床应用[J]. 中国现代医生,2009,47(9):22-23.
[12] 王国胜,余玲玲. 温州地区健康人群血浆内毒素水平调查及正常参考值范围的建立[J]. 中国现代医生,2011,49(11):13-17.
[13] 付晓伶,周荣耀,潘广文. 离子色谱法测定结直肠癌患者尿液中的甘露醇和乳果糖[J]. 分析化学,2012,40(4):608-611.
[14] Kwon C,Seung S,Suk J,et al. The effect of oral glutamine on 5-fluorouracil leucovorin- induced mucositis stomatitis assessed by intestinal permeability test[J]. Clin Nutr,2007,10(5):639-659.
[15] 范妮,田字彬,孔心涓,等. 益生菌对肝硬化患者肠黏膜通透性的影响[J]. 世界华人消化杂志,2009,17(36):3745-3748.
[16] 丘惠嫦,楼慧玲,马军,等. 四君子汤联合纤维膳食营养对老年胃肠功能不佳患者肠屏障功能的作用[J]. 广东医学,2012,33(5):2349-2350.
[17] 张大鹏,周联,张志敏,等. 四君子汤复方总多糖对肠黏膜结细胞凋亡的影响[J]. 中药新药与临床药理,2009,20(6):529-532.
[18] 朱妤,姚敏,华王翔. 加味四君子汤对巨结肠患儿肠屏障功能影响的临床观察[J] 中国中西医结合杂志,2012,32(2):199-202.
[19] 杨海波,张静喆,蔡骏,等. 大黄和早期肠内营养对肠缺血-再灌注损伤大鼠肠屏障功能的影响[J]. 肠外与肠内营养,2011,18(6):364-367.
[20] 吴洁,孙桂芝. 重视保护肠黏膜屏障延缓大肠癌复发转移及中医药防治优势[G]. 中华中医药学会脾胃病分会第二十三次全国脾胃病学术交流会论文汇编,2011:465-467.
[21] 鞠宝玲,徐艳敏,姚黎军,等. 纳米四君子汤对急性肝功能衰竭小鼠肠屏障功能的影响[J]. 中国微生态学杂志,2011,23(9):797-799.
[22] 李艺,郭利华. 李斯文. 运用葛根芩连汤治疗肠癌术后腹泻[J]. 中国中医药信息杂志,2010,17(6):85-86.
[23] 陈丽红,唐于平,王强. 葛根芩连汤的现代研究进展[J]. 中草药,2010,41(4):8-12.
[24] 魏开建. 葛根芩连汤治疗放射性肠炎的临床疗效观察[J]. 福建中医学院学报,2009,19(6):13-14.

备注/Memo

备注/Memo:
基金项目: 上海市卫生局科研项目(20139173);上海市教委科研项目(2013JW045) 收稿日期: 2014 - 03 - 21 作者简介: 付晓伶(1978-),女,黑龙江齐齐哈尔人,主治医师,研究方向:中医药防治大肠癌临床研究。 △通信作者:周荣耀,E-mail:zhoury1357@hotmail.com
更新日期/Last Update: 1900-01-01